Theobromine, a naturally occurring substance, can be
conceived
as a prospective inhibitor for uric acid clustering. In aqueous solution,
aggregates of π-stacked uric acid molecules with the larger
size of clusters are modified into lower-order clusters with a substantial
percentage of monomer by the incorporation of theobromine. The composite
made of theobromine–uric acid is expected to have enhanced
water solubility, allowing stable kidney stones to be excreted through
urine. Interestingly, the strategy for the decomposition with feasible
modifications in melamine–uric acid composites (that are hydrogen-bonded)
is developed (by implementing the cluster structure analysis technique
and binding free energies). The all-atom molecular dynamics (MD) data
provides new insights into the structure and dynamics of uric acid
along with melamine molecules in the context of aggregation. The simulation
in the present study is supported further by structural and dynamical
property calculations. The calculations of hydrogen bond dynamics,
the average number of hydrogen bonds, dimer existence autocorrelation
functions, umbrella sampling, and coordination number theorize that
the incorporation of theobromine significantly modifies the aggregated
structure of uric acid. The overall complexation energy, along with
the quantum chemical calculations, further explains the alternation
of aggregated structure. Furthermore, the preferential interaction
parameter describes at which concentration theobromine–uric
acid interaction (which is π-stacked) predominates over uric
acid–uric acid interactions. Interestingly, the interactions
between theobromine–melamine and melamine–melamine (which
are hydrogen-bonded) are not relevant here. Thus, melamine–uric
acid cluster size is reduced owing to the disintegration of self-aggregated
uric acid clusters by the involvement of theobromine. Moreover, an
excellent agreement is observed between present MD results and experimentally
obtained data.